Russell C Hirsch - Net Worth and Insider Trading

Russell C Hirsch Net Worth

The estimated net worth of Russell C Hirsch is at least $9 Million dollars as of 2024-04-23. Russell C Hirsch is the Director of Hansen Medical Inc and owns about 1,859,252 shares of Hansen Medical Inc (HNSN) stock worth over $7 Million. Russell C Hirsch is also the Director of AVEO Pharmaceuticals Inc and owns about 128,948 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $2 Million. Details can be seen in Russell C Hirsch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Russell C Hirsch has not made any transactions after 2010-12-02 and currently still holds the listed stock(s).

Transaction Summary of Russell C Hirsch

To

Russell C Hirsch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Russell C Hirsch owns 9 companies in total, including Vitae Pharmaceuticals Inc (VTAE) , Portola Pharmaceuticals Inc (PTLA) , and Hansen Medical Inc (HNSN) among others .

Click here to see the complete history of Russell C Hirsch’s form 4 insider trades.

Insider Ownership Summary of Russell C Hirsch

Ticker Comapny Transaction Date Type of Owner
VTAE Vitae Pharmaceuticals Inc 2015-03-24 10 percent owner
PTLA Portola Pharmaceuticals Inc 2013-05-28 director
HNSN Hansen Medical Inc 2012-05-25 director
AVEO AVEO Pharmaceuticals Inc 2010-12-02 director
FOLD Amicus Therapeutics Inc 2007-05-30 10 percent owner
VNDA Vanda Pharmaceuticals Inc 2006-04-12 10 percent owner
SNSS Sunesis Pharmaceuticals Inc 2005-09-27 director
ISRG Intuitive Surgical Inc 2003-12-31 director
VIRX Viracta Therapeutics Inc 2005-09-27 director

Russell C Hirsch Latest Holdings Summary

Russell C Hirsch currently owns a total of 2 stocks. Among these stocks, Russell C Hirsch owns 1,859,252 shares of Hansen Medical Inc (HNSN) as of April 21, 2010, with a value of $7 Million and a weighting of 79.32%. Russell C Hirsch also owns 128,948 shares of AVEO Pharmaceuticals Inc (AVEO) as of December 2, 2010, with a value of $2 Million and a weighting of 20.68%.

Latest Holdings of Russell C Hirsch

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HNSN Hansen Medical Inc 2010-04-21 1,859,252 3.99 7,418,415
AVEO AVEO Pharmaceuticals Inc 2010-12-02 128,948 15.00 1,934,220

Holding Weightings of Russell C Hirsch


Russell C Hirsch Form 4 Trading Tracker

According to the SEC Form 4 filings, Russell C Hirsch has made a total of 0 transactions in Hansen Medical Inc (HNSN) over the past 5 years. The most-recent trade in Hansen Medical Inc is the acquisition of 125,000 shares on April 21, 2010, which cost Russell C Hirsch around $250,000.

According to the SEC Form 4 filings, Russell C Hirsch has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the sale of 32,241 shares on December 2, 2010, which brought Russell C Hirsch around $5 Million.

Insider Trading History of Russell C Hirsch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Russell C Hirsch Trading Performance

GuruFocus tracks the stock performance after each of Russell C Hirsch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Russell C Hirsch is -23.92%. GuruFocus also compares Russell C Hirsch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Russell C Hirsch within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Russell C Hirsch's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Russell C Hirsch

Average Return

-5.44%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.65 -23.92 -25.5 -5.44 -0.68 -8.07
Relative Return to S&P 500(%) 17.98 -24.82 -39.21 -32.53 -17.12 -21.4

Russell C Hirsch Ownership Network

Ownership Network List of Russell C Hirsch

No Data

Ownership Network Relation of Russell C Hirsch


Russell C Hirsch Owned Company Details

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Russell C Hirsch is the 10 percent owner of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and Chief Medical Officer Carole Sable .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

Russell C Hirsch Mailing Address

Above is the net worth, insider trading, and ownership report for Russell C Hirsch. You might contact Russell C Hirsch via mailing address: 435 Tasso Street, Suite 200, Palo Alto Ca 94301.

Discussions on Russell C Hirsch

No discussions yet.